Cresset Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.78M	Buy	31,045 +3,288	+12%	+$818K	0.03%	304
2025 Q4	$7.64M	Sell	27,757 -428	-2%	-$117K	0.03%	293
2025 Q3	$7.39M	Buy	28,185 +648	+2%	+$157K	0.03%	280
2025 Q2	$6.03M	Sell	27,537 -1,033	-4%	-$221K	0.03%	302
2025 Q1	$6.4M	Buy	28,570 +1,022	+4%	+$282K	0.03%	312
2024 Q4	$9.02M	Sell	27,548 -2,681	-9%	-$844K	0.04%	240
2024 Q3	$9.07M	Buy	30,229 +435	+1%	+$133K	0.04%	329
2024 Q2	$9.81M	Buy	29,794 +6,018	+25%	+$2.13M	0.04%	285
2024 Q1	$9.41M	Sell	23,776 -4,361	-15%	-$1.61M	0.05%	260
2023 Q4	$9.91M	Buy	28,137 +1,270	+5%	+$449K	0.06%	212
2023 Q3	$10.1M	Buy	26,867 +569	+2%	+$220K	0.07%	213
2023 Q2	$10.1M	Buy	+26,298	New	+$9.39M	0.07%	267
2022 Q4	–	Sell	-1,333	Closed	-$328K	–	912
2022 Q3	$328K	Buy	+1,333	New	+$406K	﹤0.01%	645
2022 Q2	–	Sell	-2,373	Closed	-$974K	–	1101
2022 Q1	$974K	Sell	2,373 -6,309	-73%	-$2.47M	0.01%	418
2021 Q4	$4.07M	Buy	8,682 +3,161	+57%	+$1.36M	0.04%	171
2021 Q3	$2.34M	Buy	5,521 +2,040	+59%	+$860K	0.03%	202
2021 Q2	$1.25M	Buy	3,481 +1,345	+63%	+$444K	0.02%	299
2021 Q1	$602K	Buy	+2,136	New	+$611K	0.01%	427
2020 Q4	–	Sell	-773	Closed	-$212K	–	818
2020 Q3	$212K	Sell	773 -305	-28%	-$80.7K	﹤0.01%	629
2020 Q2	$245K	Buy	+1,078	New	+$212K	0.01%	537
2019 Q2	–	Sell	-1,051	Closed	-$116K	–	1729
2019 Q1	$116K	Buy	1,051 +116	+12%	+$12.1K	﹤0.01%	512
2018 Q4	$92K	Buy	+935	New	+$101K	0.01%	345